Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Baxter

Showing results (251-260 of 266) with videos related to

Pageof 27
Sort By:
Clinical Endocrinology|August 25, 2005
Erythropoietin administration does not influence the GH--IGF axis or makers of bone turnover in recreational athletesA E Nelson, C J Howe, T V Nguyen, et al.
Hormone Research|October 31, 2001
How should insulin-like growth factor I be measured? A consensus statementM B Ranke, U Feldt-Rasmussen, P Bang, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 1998
Recommendations for nomenclature of the insulin-like growth factor binding protein superfamilyR C Baxter, M A Binoux, D R Clemmons, et al.
Endocrinology|September 29, 1998
Recommendations for nomenclature of the insulin-like growth factor binding protein superfamilyR C Baxter, M A Binoux, D R Clemmons, et al.
The Journal of Clinical Endocrinology and Metabolism|May 14, 1999
Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletionC Camacho-Hübner, K A Woods, F Miraki-Moud, et al.
The Journal of Clinical Endocrinology and Metabolism|February 18, 1999
Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humansH Olivecrona, A Hilding, C Ekström, et al.
Clinical Endocrinology|January 5, 2000
Initial characterization of the GH-IGF axis and nutritional status of the Ati Negritos of the PhilippinesA B Clavano-Harding, G R Ambler, C T Cowell, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1993
The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3S E Gargosky, K F Wilson, P J Fielder, et al.
The Journal of Endocrinology|December 1, 1994
Valid measurements of total IGF concentrations in biological fluids. Recommendations from the 3rd International Symposium on Insulin-like Growth FactorsP Bang, R C Baxter, W F Blum, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|April 1, 1994
Effects of insulin-like growth factor I treatment on the molecular distribution of insulin-like growth factors among different binding proteinsS E Gargosky, K F Wilson, P J Fielder, et al.
Pageof 27

Showing results (251-260 of 266) with videos related to

Sort By:
Pageof 27
Clinical Endocrinology|August 25, 2005
Erythropoietin administration does not influence the GH--IGF axis or makers of bone turnover in recreational athletesA E Nelson, C J Howe, T V Nguyen, et al.
Hormone Research|October 31, 2001
How should insulin-like growth factor I be measured? A consensus statementM B Ranke, U Feldt-Rasmussen, P Bang, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 1998
Recommendations for nomenclature of the insulin-like growth factor binding protein superfamilyR C Baxter, M A Binoux, D R Clemmons, et al.
Endocrinology|September 29, 1998
Recommendations for nomenclature of the insulin-like growth factor binding protein superfamilyR C Baxter, M A Binoux, D R Clemmons, et al.
The Journal of Clinical Endocrinology and Metabolism|May 14, 1999
Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletionC Camacho-Hübner, K A Woods, F Miraki-Moud, et al.
The Journal of Clinical Endocrinology and Metabolism|February 18, 1999
Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humansH Olivecrona, A Hilding, C Ekström, et al.
Clinical Endocrinology|January 5, 2000
Initial characterization of the GH-IGF axis and nutritional status of the Ati Negritos of the PhilippinesA B Clavano-Harding, G R Ambler, C T Cowell, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1993
The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3S E Gargosky, K F Wilson, P J Fielder, et al.
The Journal of Endocrinology|December 1, 1994
Valid measurements of total IGF concentrations in biological fluids. Recommendations from the 3rd International Symposium on Insulin-like Growth FactorsP Bang, R C Baxter, W F Blum, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|April 1, 1994
Effects of insulin-like growth factor I treatment on the molecular distribution of insulin-like growth factors among different binding proteinsS E Gargosky, K F Wilson, P J Fielder, et al.
Pageof 27